Mediacom world news portal
ASTRAZENECA has struck a deal worth up to $ 400 million with Japan’s Takeda Pharmaceutical to co-develop and commercialise a potential treatment for Parkinson’s disease. Daily Express :: City and Business Feed
Read More »AstraZeneca strikes £309 million deal with Japan’s Takeda Pharmaceutical
